Who owns Artiva Biotherapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ARTV from SEC Form 13F filings across 72 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 72 institutions disclosed 40.4M shares of Artiva Biotherapeutics, Inc. worth $391.6M — about 102.4% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
72
13F holders
$391.6M
value, 2026 filers
102.4%
of shares outstanding (40.4M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ARTV's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 18.0M | $174.2M | 1.5% | 45.6% | +82.2% |
| 2 | VIKING GLOBAL INVESTORS LPNEW | 2.6M | $25.3M | 0.1% | 6.6% | new |
| 3 | Blackstone Inc.NEW | 2.4M | $23.3M | 0.1% | 6.1% | new |
| 4 | 5AM Venture Management, LLC | 2.4M | $22.8M | 7.9% | 6% | 0.0% |
| 5 | Venrock Adviser, LLC | 2.0M | $19.8M | 0.6% | 5.2% | +27.0% |
| 6 | FRANKLIN RESOURCES INC | 2.0M | $19.4M | 0.0% | 5.1% | +283.8% |
| 7 | Caligan Partners LPNEW | 1.7M | $16.8M | 0.8% | 4.4% | new |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 981,815 | $9.5M | 0.0% | 2.5% | +372.7% |
| 9 | SAMSARA BIOCAPITAL, LLCNEW | 954,861 | $9.3M | 0.8% | 2.4% | new |
| 10 | Blue Owl Capital Holdings LPNEW | 874,542 | $8.5M | 1.3% | 2.2% | new |
| 11 | Propel Bio Management, LLC | 696,436 | $6.8M | 3.5% | 1.8% | +375.8% |
| 12 | BlackRock, Inc. | 694,726 | $6.7M | 0.0% | 1.8% | +225.6% |
| 13 | CITADEL ADVISORS LLC | 609,376 | $5.9M | 0.0% | 1.5% | +3739.8% |
| 14 | SILVERARC CAPITAL MANAGEMENT, LLCNEW | 525,000 | $5.1M | 0.5% | 1.3% | new |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 353,845 | $3.4M | 0.0% | 0.9% | +247.9% |
| 16 | BOOTHBAY FUND MANAGEMENT, LLCNEW | 314,375 | $3.0M | 0.0% | 0.8% | new |
| 17 | Nantahala Capital Management, LLCNEW | 300,000 | $2.9M | 0.1% | 0.8% | new |
| 18 | Revelation Capital Management, LLC | 299,311 | $2.9M | 2.7% | 0.8% | 0.0% |
| 19 | Alyeska Investment Group, L.P. | 273,615 | $2.7M | 0.0% | 0.7% | +173.6% |
| 20 | ACUTA CAPITAL PARTNERS, LLCNEW | 260,416 | $2.5M | 1.8% | 0.7% | new |
| 21 | KVP Capital Advisors, LPNEW | 200,000 | $1.9M | 1.4% | 0.5% | new |
| 22 | WELLINGTON MANAGEMENT GROUP LLP | 194,108 | $1.9M | 0.0% | 0.5% | 0.0% |
| 23 | UBS Group AG | 184,020 | $1.8M | 0.0% | 0.5% | +11951.1% |
| 24 | SEVEN GRAND MANAGERS, LLCNEW | 175,000 | $1.7M | 0.1% | 0.4% | new |
| 25 | STATE STREET CORP | 165,764 | $1.6M | 0.0% | 0.4% | +362.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.